Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gottesman

Showing results (501-510 of 602) with videos related to

Pageof 61
Sort By:
Cancer Chemotherapy and Pharmacology|February 16, 2008
Disruption of microfilaments by cytochalasin B decreases accumulation of cisplatin in human epidermal carcinoma and liver carcinoma cell linesXing-Jie Liang, Jun-Jie Yin, Barbara Taylor, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2013
Bioluminescent imaging of drug efflux at the blood-brain barrier mediated by the transporter ABCG2Joshua Bakhsheshian, Bih-Rong Wei, Ki-Eun Chang, et al.
Experimental Cell Research|December 24, 2018
Targeting mitochondrial hexokinases increases efficacy of histone deacetylase inhibitors in solid tumor modelsAndrew J McDonald, Katherine M Curt, Ruchi P Patel, et al.
Breast Cancer Research and Treatment|January 1, 1987
Molecular biology of drug resistanceA Fojo, M Cornwell, C Cardarelli, et al.
Blood|February 15, 1992
Transplantation of bone marrow cells from transgenic mice expressing the human MDR1 gene results in long-term protection against the myelosuppressive effect of chemotherapy in miceG H Mickisch, I Aksentijevich, P V Schoenlein, et al.
ACS Chemical Neuroscience|July 11, 2012
The "specific" P-glycoprotein inhibitor Tariquidar is also a substrate and an inhibitor for breast cancer resistance protein (BCRP/ABCG2)Pavitra Kannan, Sanjay Telu, Suneet Shukla, et al.
Experimental Cell Research|January 24, 2020
A role for ceramide glycosylation in resistance to oxaliplatin in colorectal cancerJames P Madigan, Robert W Robey, Joanna E Poprawski, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2002
Drug selection with paclitaxel restores expression of linked IL-2 receptor gamma -chain and multidrug resistance (MDR1) transgenes in canine bone marrowThomas Licht, Mark Haskins, Paula Henthorn, et al.
The Journal of Biological Chemistry|June 5, 1991
Decreased catalytic subunit mRNA levels and altered catalytic subunit mRNA structure in a cAMP-resistant Chinese hamster ovary cell lineP Howard, K H Day, K E Kim, et al.
Experimental Cell Research|June 24, 2015
Expression of the multidrug transporter P-glycoprotein is inversely related to that of apoptosis-associated endogenous TRAILPaloma S Souza, James P Madigan, Jean-Pierre Gillet, et al.
Pageof 61

Showing results (501-510 of 602) with videos related to

Sort By:
Pageof 61
Cancer Chemotherapy and Pharmacology|February 16, 2008
Disruption of microfilaments by cytochalasin B decreases accumulation of cisplatin in human epidermal carcinoma and liver carcinoma cell linesXing-Jie Liang, Jun-Jie Yin, Barbara Taylor, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2013
Bioluminescent imaging of drug efflux at the blood-brain barrier mediated by the transporter ABCG2Joshua Bakhsheshian, Bih-Rong Wei, Ki-Eun Chang, et al.
Experimental Cell Research|December 24, 2018
Targeting mitochondrial hexokinases increases efficacy of histone deacetylase inhibitors in solid tumor modelsAndrew J McDonald, Katherine M Curt, Ruchi P Patel, et al.
Breast Cancer Research and Treatment|January 1, 1987
Molecular biology of drug resistanceA Fojo, M Cornwell, C Cardarelli, et al.
Blood|February 15, 1992
Transplantation of bone marrow cells from transgenic mice expressing the human MDR1 gene results in long-term protection against the myelosuppressive effect of chemotherapy in miceG H Mickisch, I Aksentijevich, P V Schoenlein, et al.
ACS Chemical Neuroscience|July 11, 2012
The "specific" P-glycoprotein inhibitor Tariquidar is also a substrate and an inhibitor for breast cancer resistance protein (BCRP/ABCG2)Pavitra Kannan, Sanjay Telu, Suneet Shukla, et al.
Experimental Cell Research|January 24, 2020
A role for ceramide glycosylation in resistance to oxaliplatin in colorectal cancerJames P Madigan, Robert W Robey, Joanna E Poprawski, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2002
Drug selection with paclitaxel restores expression of linked IL-2 receptor gamma -chain and multidrug resistance (MDR1) transgenes in canine bone marrowThomas Licht, Mark Haskins, Paula Henthorn, et al.
The Journal of Biological Chemistry|June 5, 1991
Decreased catalytic subunit mRNA levels and altered catalytic subunit mRNA structure in a cAMP-resistant Chinese hamster ovary cell lineP Howard, K H Day, K E Kim, et al.
Experimental Cell Research|June 24, 2015
Expression of the multidrug transporter P-glycoprotein is inversely related to that of apoptosis-associated endogenous TRAILPaloma S Souza, James P Madigan, Jean-Pierre Gillet, et al.
Pageof 61